Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,917 | 1,020 | 1,659 | 971 | 488 |
| Depreciation Amortization | 139 | 65 | 284 | 206 | 140 |
| Income taxes - deferred | 94 | 77 | 469 | 283 | 245 |
| Accounts receivable | -865 | -1,640 | -707 | -592 | -124 |
| Accounts payable and accrued liabilities | -609 | -1,000 | 1,639 | 553 | 183 |
| Other Working Capital | -397 | -735 | -434 | 66 | -150 |
| Other Operating Activity | 1,474 | 2,640 | -932 | 39 | -59 |
| Operating Cash Flow | $1,753 | $427 | $1,978 | $1,526 | $723 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -117 | -70 | -1,238 | -1,076 | -55 |
| Investing Cash Flow | $-117 | $-70 | $-1,238 | $-1,076 | $-55 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 24 | 24 | 24 |
| Financing Cash Flow | $N/A | $N/A | $24 | $24 | $24 |
| Beginning Cash Position | 3,654 | 3,654 | 2,890 | 2,890 | 2,890 |
| End Cash Position | 5,290 | 4,011 | 3,654 | 3,364 | 3,582 |
| Net Cash Flow | $1,636 | $357 | $764 | $474 | $692 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,753 | 427 | 1,978 | 1,526 | 723 |
| Capital Expenditure | -117 | -70 | -1,238 | -1,076 | -55 |
| Free Cash Flow | 1,636 | 357 | 740 | 450 | 668 |